Rastogi Vinamr, O'Donnell Thomas F X, Marcaccio Christina L, Patel Priya B, Varkevisser Rens R B, Yadavalli Sai Divya, de Bruin Jorg L, Verhagen Hence J M, Patel Virendra I, Schermerhorn Marc L
Department of Surgery, Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
Division of Vascular Surgery and Endovascular Interventions, Columbia University Irving Medical Center, New York, NY.
J Vasc Surg. 2024 Feb;79(2):269-279. doi: 10.1016/j.jvs.2023.10.006. Epub 2023 Oct 14.
One-year aneurysm sac changes have previously been found to be associated with mortality and may have the potential to guide personalized follow-up following endovascular aneurysm repair (EVAR). In this study, we examined the association of these early sac changes with long-term reintervention and rupture.
We identified all patients undergoing first-time EVAR for intact abdominal aortic aneurysm between 2003 and 2018 in the Vascular Quality Initiative with linkage to Medicare claims for long-term outcomes. We included patients with an imaging study at 1 year postoperatively. Aneurysm sac behavior was defined as per the Society for Vascular Surgery guidelines: stable sac (<5 mm change), sac regression (≥5 mm), and sac expansion (≥5 mm). Outcomes included mortality, reintervention, and rupture within 8 years, which were assessed with Kaplan-Meier methods and multivariable Cox regression analysis. Secondarily, we utilized polynomial spline interpolation to demonstrate the continuous relationship of diameter change to 8-year hazard of reintervention, rupture, or mortality as a composite outcome.
Of 31,185 EVAR patients, 16,102 (52%) had an imaging study at 1 year and were included in this study. At 1 year, 44% of sacs remained stable, 49% regressed, and 6.2% displayed expansion. Following risk adjustment, compared with a stable sac at 1 year, sac regression was associated with lower 8-year mortality (49% vs 53%; hazard ratio [HR], 0.92; 95% confidence interval [CI], 0.85-0.99; P = .036), reintervention rate (8.9% vs 15%; HR, 0.58; 95% CI, 0.50-0.68; P < .001), and rupture rate (2.0% vs 4.0%; HR, 0.45; 95%CI, 0.29-0.69; P < .001). Conversely, compared with a stable sac, sac expansion was associated with higher 8-year mortality (64% vs 53%; HR, 1.31; 95% CI, 1.14-1.51; P < .001) and reintervention rate (27% vs 15%; HR, 1.98; 95% CI, 1.57-2.51; P < .001), but similar risk of rupture (7.2% vs 4.0%; HR, 1.61; 95% CI, 0.88-2.96; P = .12). Polynomial spline interpolation demonstrated that, compared with no diameter change at 1 year, increased sac regression was associated with an incrementally lower risk of late outcomes, whereas increased sac expansion was associated with an incrementally higher risk of late outcomes.
Following EVAR, compared with a stable sac at 1-year imaging, sac regression and expansion are associated with a lower and higher risk respectively of long-term mortality, reinterventions, and ruptures. Moreover, the amount of regression or expansion seems to be incrementally associated with these late outcomes, too. Future studies are needed to determine how to improve 1-year sac regression, and whether it is safe to extend follow-up intervals for patients with regressing sacs.
此前已发现动脉瘤囊一年变化与死亡率相关,且可能有潜力指导血管内动脉瘤修复术(EVAR)后的个性化随访。在本研究中,我们探讨了这些早期囊变化与长期再次干预和破裂之间的关联。
我们在血管质量倡议组织中确定了2003年至2018年间所有因完整腹主动脉瘤首次接受EVAR的患者,并将其与医疗保险索赔数据相联系以获取长期预后信息。我们纳入了术后1年进行影像学检查的患者。动脉瘤囊行为根据血管外科学会指南定义为:囊稳定(变化<5毫米)、囊缩小(≥5毫米)和囊扩张(≥5毫米)。结局包括8年内的死亡率、再次干预和破裂,采用Kaplan-Meier方法和多变量Cox回归分析进行评估。其次,我们利用多项式样条插值法来展示直径变化与作为复合结局的8年再次干预、破裂或死亡风险之间的连续关系。
在31185例EVAR患者中,16102例(52%)在1年时进行了影像学检查并纳入本研究。1年时,44%的囊保持稳定,49%缩小,6.2%扩张。经过风险调整后,与1年时囊稳定的患者相比,囊缩小与8年较低的死亡率相关(49%对53%;风险比[HR],0.92;95%置信区间[CI],0.85 - 0.99;P = 0.036)、再次干预率相关(8.9%对15%;HR,0.58;95%CI,0.50 - 0.68;P < 0.001)以及破裂率相关(2.0%对4.0%;HR,0.45;95%CI,0.29 - 0.69;P < 0.001)。相反,与囊稳定的患者相比,囊扩张与8年较高的死亡率相关(64%对53%;HR,1.31;95%CI,1.14 - 1.51;P < 0.001)和再次干预率相关(27%对15%;HR,1.98;95%CI,1.57 - 2.51;P < 0.001),但破裂风险相似(7.2%对4.0%;HR,1.61;95%CI,0.88 - 2.96;P = 0.12)。多项式样条插值法表明,与1年时直径无变化相比,囊缩小增加与晚期结局风险逐渐降低相关,而囊扩张增加与晚期结局风险逐渐升高相关。
EVAR术后,与1年影像学检查时囊稳定的情况相比,囊缩小和扩张分别与长期死亡率、再次干预和破裂的较低和较高风险相关。此外,缩小或扩张的程度似乎也与这些晚期结局逐渐相关。未来需要开展研究以确定如何改善1年时的囊缩小情况,以及对于囊缩小的患者延长随访间隔是否安全。